INTRODUCTION
============

The acetylation and deacetylation of histones play an important role in both transcriptional repression and activation. For example, the acetylation of nucleosomes, primarily histones H3 and H4, promotes transcription initiation ([@B3]). In budding yeast, the SAGA complex contains the Gcn5p histone acetyltransferase (HAT; [@B32]), which induces the transcription of many gene sets, especially those regulated by environmental stimuli ([@B20]). Conversely, transcriptional repression is mediated by histone deacetylases (HDACs), which are recruited to promoters by sequence-specific DNA-binding proteins ([@B40]). The opposing activities of these enzymes represent a major regulatory mechanism controlling transcription initiation.

In addition to histones, there is a rapidly growing list of transcription factors that are also modified by acetylation (for review see [@B36]). For example, acetylation of p53 and GATA-1 by p300 increases their respective DNA-binding activities ([@B17]; [@B5]). Acetylation of TAL1 is reported to enhance DNA-binding activity, as well as prevent association of the corepressor mSin3 ([@B19]). Acetylation increases the stability of myc ([@B29]) and promotes protein:protein interactions for α-importin ([@B2]). Therefore, similar to histone modifications, the acetylation of transcription factors is also a mechanism to elevate gene expression.

In *Saccharomyces cerevisiae*, many of the genes required for meiosis and spore formation are repressed during mitotic cell division but transiently expressed at defined stages during development ([@B8]; [@B31]). Vegetative repression of the early meiotic gene (EMG) class requires the sequence-specific DNA-binding protein Ume6p ([@B38]). Ume6p represses transcription by recruiting both the HDAC Rpd3p ([@B23]) and the chromatin-remodeling factor Isw2p ([@B15]) to EMG promoters. To relieve this repression in meiotic cells, Ume6p is destroyed in a two-step process by the Cdc20p-activated, anaphase-promoting complex/cyclosome (APC/C) ubiquitin ligase ([@B28]). The first step partially degrades Ume6p and occurs when cultures are shifted to non--dextrose-containing growth medium. Shifting to sporulation medium, which lacks nitrogen and dextrose, induces the expression of Ime1p, a meiosis-specific factor whose association induces final Ume6p destruction and full EMG transcription. In this study, we report that acetylation of Ume6p by the Gcn5p-dependent SAGA complex provides the signal for the first step in Ume6p destruction during vegetative growth. In addition, Ume6p acetylation promotes step 2 destruction, thus stimulating the transition between mitotic cell division and meiotic development.

RESULTS
=======

Gcn5p acetylates Ume6p in vitro
-------------------------------

A previous study found that Gcn5p is required for meiotic gene induction ([@B6]). We obtained a similar result in cells that failed to destroy Ume6p ([@B28]), suggesting a mechanistic link between the two factors. Because Ume6p is a basic protein (pI 10.4) with a high concentration of lysines in the carboxy terminus of the protein (amino acids 726--836), we tested whether a glutathione *S*-transferase (GST) fusion protein (GST-Ume6^726-836^) was an in vitro substrate of Gcn5p. As expected, two Gcn5p-containing HAT complexes, SAGA and ADA, as well as recombinant Gcn5 (rGcn5), acetylated free histone H3 or H4 ([Figure 1A](#F1){ref-type="fig"}; quantitated in [Figure 1B](#F1){ref-type="fig"}). GST-Ume6^726-836^ was also a substrate of both the SAGA and ADA complexes, but not rGcn5. Previous studies also found that only SAGA, and not rGcn5, is able to acetylate nucleosomes ([@B42]; [@B16]). Therefore the finding that rGcn5 is not active suggested that Ume6p acetylation by SAGA may be physiological. To verify that Ume6p acetylation occurs in vivo, cultures expressing either a single-epitope tagged allele of *UME6* (*T7-UME6*) under the control of the *GAL1* promoter or the vector control were grown for 2 h in galactose medium containing ^14^C-acetyl-CoA. Extracts prepared from these cultures were incubated with a T7 monoclonal antibody (mAb) and the immunoprecipitates subjected to PAGE and fluorography. A signal migrating at the expected size of Ume6p was observed in the *GAL-T7-UME6* extract but not in the control immunoprecipitate ([Figure 1C](#F1){ref-type="fig"}). These results indicate that Ume6p is acetylated in vivo. FIGURE 1:Ume6p is a substrate of acetyltransferase complexes. (A) Affinity-purified acetyltransferase fractions or recombinant Gcn5p were incubated with GST-Ume6^721-831^ or the four histones. The reactions were split, with one-half separated by PAGE and fluorographed or quantitated (B) by liquid scintillation spectroscopy (dpm). (C) Wild-type strain RSY10 harboring *GAL*-T7-*UME6* expression plasmid (+) or vector control (--) was grown in the presence of ^14^C-acetyl-CoA. Extracts derived from these cultures were immunoprecipitated with T7 mAb, and the immunoprecipitates were separated by PAGE and then visualized by fluorography. Whole-cell extracts (WCEs) controlled for equal protein loading and labeling. (D) Acetylation occurs in a region adjacent to the C~6~ zinc-cluster DNA-binding domain of Ume6p. The sequence of the last 110 amino acids of Ume6p (726--836) is presented. The acetylated residues are indicated by the asterisks. The cysteines making up the C~6~ zinc cluster are in boldface and boxed. The Ime1p and Sin3p interaction domains are indicated.

Three lysines are modified by Gcn5p in vitro and in vivo
--------------------------------------------------------

The in vitro data indicated that the last 110 amino acids of Ume6p are acetylated by a Gcn5p-containing HAT complex. To identify which residues are modified, we performed mass spectrometry on the GST-Ume6 following an in vitro acetylation assay. These spectra revealed three clustered acetylated lysine residues (for representative spectra, see Supplemental Figure S1A). The three residues K736, K737, and K745 were modified either individually or in tandem for K736 and K737. These residues (identified by asterisks, [Figure 1D](#F1){ref-type="fig"}) lie outside of the Zn~2~Cys~6~ zinc-cluster DNA-binding domain (cysteines in boldface). To verify the mass spectroscopy results, the ability of SAGA to acetylate Gst-Ume6p mutants containing K → R substitutions was tested. We observed a significant reduction in activity on the GST-Ume6^K736R^ peptide or the K736R;K737R double mutant. Only a modest reduction was observed with the K737R or K745R single-mutant derivatives ([Figure 2A](#F2){ref-type="fig"}). Acetylation was reduced, but was still present, on the triple mutant (KallR) peptide, indicating that additional modified residues exist. These findings indicate that K736, K737, and K745 are acetylated by SAGA in vitro and that K736 is the preferred residue for modification. FIGURE 2:In vivo Ume6p acetylation requires Gcn5p. (A) In vitro acetylation assays described in [Figure 1](#F1){ref-type="fig"} were repeated with the indicated Gst-Ume6 substitution mutants as substrate. Gels were Coomassie stained (Coom.) before fluorography and used to control for substrate addition. (B) Extracts prepared from log-phase RSY10 cultures expressing the indicated *GAL*-T7-*UME6* alleles (or the vector control) were blotted and probed with α-K736-Ac antibodies. (C) The experiment described in B was repeated in the wild-type (RSY10) and *gcn5*∆ mutant (RSY622) strains. (D) Endogenous Ume6p (RSY1079) or Ume6p^KallR^ (RSY1149) was detected in extracts derived from mid-log cultures growing in dextrose, acetate, or after the switch from acetate to SPM. K736 acetylation was monitored by Western blot analysis probing with α-K736-Ac. Ponceau staining of the gel is shown as loading control.

To determine whether these lysine residues were modified in vivo, antibodies were raised against modified peptides acetylated at K736 and K745 (Supplemental Figure S1B). Antibodies directed against acetylated K737 were not sufficiently specific for further study. To determine whether Ume6p is acetylated on these residues in vivo, wild-type T7-Ume6p or the lysine-to-arginine substitution mutant proteins just described were expressed under the control of the *GAL1* promoter. Extracts prepared from mid-log cultures were immunoprecipitated with T7 mAb and then probed with the αK736-Ac antibody. A signal was detected for Ume6p and Ume6p^K745R^ but not with the K736R, K737R, or double K736R;K737R substitution mutant proteins ([Figure 2B](#F2){ref-type="fig"}). These findings confirm that Ume6p is modified on K736 in vivo and suggest that K736 and K737 modifications may be linked, whereas K745 acetylation is independent. Next we determined whether in vivo K736 acetylation was dependent on SAGA. For this experiment, *GCN5* was deleted in the strain expressing *GAL1*-T7-*UME6*. Extracts prepared from mid-log-phase galactose cultures were immunoprecipitated with T7 mAb and the immunoprecipitates subjected to Western blot analysis probing for acetylated K736. This study revealed that K736 acetylation was dependent on Gcn5p ([Figure 2C](#F2){ref-type="fig"}), indicating that K736 is an in vitro and in vivo target of SAGA.

Dextrose prevents Ume6p acetylation
-----------------------------------

Previous studies found that Gcn5p was recruited to promoters under low-dextrose culture conditions ([@B41]). To determine whether Ume6p acetylation was regulated by carbon source, wild-type T7-*UME6* or T7-*UME6^KallR^* alleles were integrated into the genome, placing these constructions under the control of the natural *UME6* promoter. Western blot analysis was performed on extracts prepared from cultures growing in medium using dextrose or acetate as a carbon source. Probing the blot with the αK736-Ac--specific antibody revealed a signal in the acetate culture but not in the culture growing on dextrose ([Figure 2D](#F2){ref-type="fig"}). In addition, a K736-Ac signal was also observed in extracts obtained from a culture incubated in sporulation medium (SPM) that contains acetate as the carbon source but lacks nitrogen. This signal was reduced most likely due to the destruction of Ume6p associated with meiotic entry. These findings indicate that Ume6p acetylation occurs in the absence of dextrose. To expand these results, we conducted a time-course study to determine whether Ume6p acetylation status changed upon meiotic entry. For these studies, endogenous T7-Ume6p was immunoprecipitated from extracts prepared from a culture before and after transfer to SPM. Overall levels of Ume6p were reduced as expected upon meiotic entry (Supplemental Figure S1C). Probing these extracts with αK736-Ac or αK745-Ac antibodies revealed a loss of signal consistent with the observed reduction in Ume6p levels. These results suggest that the acetylation status of these two residues did not significantly change upon meiotic induction.

Acetylation mediates Ume6p destruction
--------------------------------------

Our previous studies found that switching cultures from dextrose- to acetate-based medium reduces Ume6p steady state levels ∼50% ([@B28]). To determine whether acetylation regulated Ume6p stability, integrated mutant alleles of *UME6* that substituted all three K736, K737, and K745 residues to arginine (KallR) or glutamine (KallQ) were integrated into the *UME6* locus. The arginine substitutions prevent acetylation while preserving the basic charge, and the introduction of glutamine residues can mimic Gcn5p-dependent acetylation ([@B43]). As observed previously, wild-type Ume6p levels were reduced \>50% in acetate cultures compared with dextrose-grown cells ([Figure 3A](#F3){ref-type="fig"}). However, levels of the acetylation-deficient Ume6p^KallR^ remained unchanged in either medium, suggesting that modification of these residues is required for acetate-induced degradation. Consistent with this model, the KallQ mutant exhibited reduced steady-state levels in either dextrose- or acetate-containing medium. If Gcn5p-dependent acetylation reduced Ume6p levels in acetate medium, then eliminating Gcn5p should prevent this destruction. Therefore wild-type Ume6p levels were monitored in *gcn5*∆ culture growing in either dextrose or acetate medium. As predicted, Ume6p levels remained elevated in acetate *gcn5*∆ culture. These results indicate that Gcn5p-dependent acetylation is required for Ume6p degradation in acetate medium. FIGURE 3:Acetylation promotes Ume6p destruction. (A) Steady-state levels of endogenous Ume6p (RSY1079), Ume6p^KALLR^ (RSY1149), Ume6p^KALLQ^ (RSY1226), or Ume6p in a *gcn5*∆ mutant (∆, RSY1091) were determined by Western blot analysis of extracts derived from log-phase dextrose or acetate cultures as indicated. The blots were stripped and reprobed for tubulin to calculate relative levels of the Ume6p derivatives. *UME6* alleles: K, wild type; R, KallR; Q, KallQ. (B) Quantitative PCR was used to monitor *UME6* mRNA in strains containing the chromosomal wild-type (K), KallR (R), and KallQ (Q) alleles grown to mid-log phase in dextrose or acetate medium as indicated. Experiments conducted in *gcn5*∆ or *rpd3*∆ mutants with wild-type *UME6* are indicated. All values were normalized to internal *ENO1* mRNA concentrations with *UME6* levels in dextrose medium set at 1. Error bars indicate SEM from triplicate replicates from two independent cultures. (C) Half-life determinations of Ume6p and Ume6p^K745R^. Extracts prepared from G2-arrested (0 min) and released cultures were probed for Ume6p or Ume6p^K745R^. See *Materials and Methods* for details. Tub1p levels served as a loading control. (D) Quantification of the results indicated in C are shown (see *Materials and Methods* for details). Half-lives were determined by linear regression analysis (linear correlation, \>0.9) for two independent experiments. Dashed line indicates 50% initial protein levels.

To test whether the differences in Ume6p levels observed in [Figure 3A](#F3){ref-type="fig"} were due to changes in transcription, we determined mRNA levels of *UME6 UME6^KallR^* and *UME6^KallQ^* by quantitative PCR (qPCR) in mid-log-phase dextrose or acetate cultures. Despite the low levels of Ume6p^KallQ^ in both glucose and acetate medium, no significant differences in mRNA levels were observed between *UME6* and *UME6^KallQ^*. These finding indicate that the reduction of Ume6p^KallQ^ in dextrose or in acetate cultures cannot be explained by changes in mRNA levels. Next we observed an approximate twofold elevation in *UME6* mRNA levels in the *gcn5*∆ strain growing in acetate ([Figure 3B](#F3){ref-type="fig"}). However, Ume6p concentrations were slightly reduced in the *gcn5*∆ acetate culture compared with the wild-type dextrose control. Taken together, these studies did not find a correlation between mRNA and protein levels, suggesting that the differences in concentration observed between Ume6p and the two derivatives were due to a posttranscriptional event.

To determine whether the differences in steady-state Ume6p levels reflected changes in stability, we calculated Ume6p and Ume6p^K745R^ half-lives in G2 cells (see *Materials and Methods* for details). The K745R mutation was used in this study, as it appears to provide a similar level of stabilization as the KallR allele (see later discussion of [Figure 5](#F5){ref-type="fig"}; also, unpublished data). It was important to enrich the cultures in G2, as APC/C^Cdc20^ is only active from anaphase through early G1 ([@B24]). Wild-type cultures harboring plasmids containing either *UME6* or *UME6^K745R^* under the control of the galactose-inducible promoter *GAL1* were grown to mid-log phase in acetate medium. Acetate medium permits Ume6p acetylation and does not induce or repress the *GAL1* promoter. *GAL1*-*UME6* and *GAL1*-*UME6^K745R^* were induced by the addition of galactose, and the cultures were arrested in G2 by the addition of nocodazole. Under these conditions APC/C^Cdc20^ is not functional, due to spindle checkpoint activation ([@B21]), allowing Ume6p accumulation. After 2.5 h, the G2-arrested cultures (determined by 4′,6-diamidino-2-phenylindole \[DAPI\] staining) were released by washing out the drug, allowing APC/C reactivation. Glucose and cycloheximide were then added to the medium to inhibit *GAL1*-*UME6* and *GAL1*-*UME6^K745R^* mRNA transcription and translation, respectively. Western blot analysis from samples taken of arrested cultures and following release revealed that Ume6p^K745R^ was approximate twofold more stable than the wild-type protein ([Figure 3C](#F3){ref-type="fig"}; quantified in [Figure 3D](#F3){ref-type="fig"}). Taken together with the mRNA analysis, these results indicate that Gcn5p-dependent acetylation increases Ume6p turnover. FIGURE 4:Ume6p is a substrate for the Rpd3p HDAC. (A) Ume6p levels were monitored in the wild-type (RSY1079) or *rpd3*∆ (RSY1632) strains and Ume6p^KallR^ in the *rpd3*∆ strain (RSY1622) in acetate or dextrose medium as indicated. The relative levels of the Ume6p signal were normalized to Tub1p and then standardized to the wild-type protein in dextrose medium. ND, not detectable above background. (B) In vitro ^3^H-acetyl-CoA--modified Ume6p or histone H3 generated as described in [Figure 2A](#F2){ref-type="fig"} was incubated with HDAC1 for increasing time (0, 2, 4 h). Reactions were separated by PAGE and then subjected to Coomassie staining and fluorography. (C) *SPO13* mRNA levels were quantitated by qPCR in wild-type (+, RSY1079), *gcn5*∆ (RSY1634), or *rpd3*∆ (RSY1636) mutants expressing the indicated *UME6* alleles as described in [Figure 3A](#F3){ref-type="fig"}. Cultures were grown to mid-log phase in either dextrose-based (open bars) or acetate-based (closed bars) medium. *SPO13* mRNA levels were determined by qPCR and presented following standardization to *ENO1* transcript concentrations for each sample. *SPO13* mRNA level in the dextrose-grown *UME6* culture was set at 1. Error bars were calculated from three biological replicates. FIGURE 5:Acetylation is required for meiotic Ume6p destruction. (A) Steady-state levels of endogenous T7-Ume6p (RSY1079), T7-Ume6p^K745R^ (RSY1148), T7-Ume6p^KallR^ (RSY1149), T7-Ume6p^K736,737R^ (RSY1147), T7-Ume6p^K736R^ (RSY1145), and T7-Ume6p^K737R^ (RSY1146) were determined by Western blot analysis of extracts prepared from cultures in acetate medium (0 h) or after transfer to SPM (at indicated hours). Tub1p served as a loading control. (B) The experiments described in A were repeated with strains RSY1079 (WT), RSY1149 (T7-Ume6p^KallR^), and RSY1226 (T7-Ume6p^KallQ^) during an extended meiotic time course. (C) A *cdc20-1* mutant strain expressing T7-tagged, wild-type *UME6* (RSY1101) or *UME6^KALLQ^* (RSY1623) were grown at the permissive temperature (23°C) and then transferred to SPM. After 4 h, the cultures were shifted to the restrictive temperature (34.5°C) and the time course continued. Levels of Ume6p and Ume6p^KallQ^ were determined by Western blot analysis. Tub1p levels were monitored as a loading control.

Ume6p is a substrate for HDAC1
------------------------------

Ume6p tethers the HDAC Rpd3p to early meiotic gene promoters. We next examined whether Rpd3p antagonizes Gcn5p activity to maintain high Ume6p levels in dextrose cultures. As described, Ume6p steady-state levels are reduced ∼50% when the culture is shifted from dextrose to acetate medium ([Figure 4A](#F4){ref-type="fig"}). Surprisingly, Ume6p and Ume6p^KallR^ levels increased approximately twofold in the dextrose *rpd3*∆ mutant cultures ([Figure 4A](#F4){ref-type="fig"}). These results suggest that Ume6p levels are modulated by acetylation even in dextrose medium. In acetate cultures, the loss of Rpd3p activity exacerbated the negative affect of this medium on Ume6p stability. This result was not due to changes in *UME6* mRNA concentrations in the *rpd3*∆ strain ([Figure 3B](#F3){ref-type="fig"}). Consistent with our model, preventing acetylation (KallR) protected Ume6p from destruction in *rpd3*∆ mutants growing in acetate medium. These results are consistent with a model in which Rpd3p promotes Ume6p stability through deacetylation of these lysines.

We next determined whether Rpd3p directly regulates the acetylation status of Ume6p. First, His~6~-Ume6p^726-836^ was acetylated by SAGA in the presence of ^3^H-acetyl-CoA as described in [Figure 2](#F2){ref-type="fig"}. Histone H3 was also modified to serve as a positive control. The acetylation reactions were stopped and then incubated with HDAC1, the human orthologue of Rpd3p ([@B39]). Time points were taken and the products separated by SDS--PAGE and subjected to fluorography. These experiments revealed that Ume6p acetylation was reduced in a time-dependent manner ([Figure 4B](#F4){ref-type="fig"}), indicating that it is indeed a substrate for HDAC1. Taken together, these results indicate that Ume6p acetylation, and ultimately its stability, is a dynamic process controlled by the opposing activities of Gcn5p and Rpd3p. Shifting the balance of these activities may represent an important switch in the decision between cellular proliferation and meiotic differentiation.

Acetylation-induced destruction partially relieves Ume6p repression
-------------------------------------------------------------------

To determine whether changes in Ume6p levels affected its ability to function as a transcriptional repressor, we measured mRNA levels of the EMG *SPO13* in vegetative cultures growing in dextrose or acetate medium. An approximate threefold increase in *SPO13* mRNA levels was observed in wild-type *UME6*-expressing culture upon its transfer to acetate medium ([Figure 4C](#F4){ref-type="fig"}). This acetate-induced derepression was lost in cells expressing the KallR mutant, indicating that maintaining Ume6p at dextrose levels decreased *SPO13* mRNA levels in this medium. Consistent with this model, the introduction of the glutamine residues derepressed *SPO13* in dextrose medium to levels observed in acetate-grown cultures. No additive effect in *SPO13* derepression was observed when the *UME6^KallQ^*-expressing culture was grown in acetate medium. This result argues that the derepression observed in the KallQ mutation and in acetate medium function through the same pathway. These results indicate that the EMG derepression observed in acetate medium is controlled by acetylation-induced reduction in Ume6p levels. Next we determined whether the KallQ mutation relieved the requirement for Gcn5p in EMG derepression. To address this question, we examined *SPO13* mRNA levels in a *gcn5*∆ mutant expressing Ume6p^KallQ^. In both dextrose and acetate medium, Gcn5p was required for *SPO13* depression in the KallQ-expressing strain, indicating that additional targets (e.g., nucleosomes) are modified to allow *SPO13* mRNA induction. Taken together, our findings indicate that the deacetylation and acetylation of Ume6p control both its stability and its ability to fully repress *SPO13* transcription.

Acetylation accelerates Ume6p meiotic destruction
-------------------------------------------------

Early meiotic gene induction requires complete Ume6p destruction as cells transit from mitotic to meiotic cell division. To determine whether the acetylation status of Ume6p affects its meiotic destruction kinetics, we performed a series of time-course experiments. Plasmids expressing the various K → R substitution mutant proteins were introduced into a wild-type strain and their destruction followed by Western blot analysis. The K736R and K737R single-mutant proteins displayed destruction kinetics similar to the wild type ([Figure 5A](#F5){ref-type="fig"}). However, the K745R single mutant and the K736R;K737R double mutant were protected from rapid degradation upon meiotic induction. To more fully investigate this observation, an extended time course was conducted with strains expressing either the wild-type or the integrated *UME6^KallR^* allele. Western blot analysis revealed that Ume6p^KallR^ destruction was delayed approximately 6 h compared with wild type ([Figure 5B](#F5){ref-type="fig"}). These results suggest that acetylation of the lysine cluster is required for the rapid meiotic destruction of Ume6p but is not essential for the process to eventually occur. Consistent with this model, Ume6p^KallQ^ displayed accelerated destruction kinetics, with its levels reduced below the limits of detection within 3 h after the shift to SPM ([Figure 5B](#F5){ref-type="fig"}, bottom). Of interest, unlike wild type or Ume6p^KallR^, Ume6p^KallQ^ was not detected late in meiosis during spore wall assembly (at 24 h). These results suggest that maintaining newly synthesized Ume6p in the deacetylated state is important to allow reaccumulation of Ume6p after spore morphogenesis.

The Cdc20p-directed APC/C is required for Ume6p destruction as cells enter meiosis ([@B28]). Therefore we next determined whether the rapid destruction of Ume6p^KallQ^ was dependent on APC/C^Cdc20^ or was due to nonspecific protein instability. Because Cdc20p is required for cell growth, we used a temperature-sensitive allele of *CDC20* (*cdc20-1*). Meiotic time-course experiments were repeated with a *cdc20-1* stain expressing either Ume6p or Ume6p^KallQ^. Cultures were grown at the permissive temperature (23°C) and then transferred to SPM at the same temperature. After 4 h, the cultures were shifted to the restrictive temperature (34.5°C). Western blot analysis before and after the temperature shift revealed that although Ume6p^KallQ^ levels dropped below the limits of detection by 3 h, they rebounded to detectable levels after inactivation of Cdc20-1p ([Figure 5C](#F5){ref-type="fig"}). These findings indicate that Ume6p^KallQ^ instability is dependent on APC/C^Cdc20^.

Ume6p acetylation is required for normal meiotic gene induction
---------------------------------------------------------------

The persistence of Ume6p^KallR^ after meiotic entry suggested the possibility that EMG transcription was delayed, as observed when Ume6p was protected from destruction by mutating its destruction box ([@B28]). To test this possibility, we evaluated the mRNA expression profiles of genes from the early (*SPO13*), middle (*SPS4*), or late (*SPS100*) expression classes by Northern blot analysis of samples collected from an extended time-course experiment. This study revealed a complex transcription profile for these loci. Both *SPO13* and *SPS4* mRNA were observed at the same time point (6 and 12 h, respectively) in both strains ([Figure 6A](#F6){ref-type="fig"}). However, their induction kinetics were altered, in that peak expression intensity was reduced in the Ume6p^KallR^ strain, and the genes failed to reestablish repression. A caveat to this conclusion is that the synchrony of meiotic progression may be perturbed in the Ume6p^KallR^ strain, thus broadening the expression peaks (see later discussion). *SPS100* mRNA accumulation was delayed compared with wild type and did not peak within the time frame of this experiment. Taken together, these results indicate that efficient acetylation-dependent destruction of Ume6p is required to maintain the normal meiotic transcription program. FIGURE 6:Ume6p acetylation is required for normal meiotic gene expression and progression. (A) Northern blot analysis of early (*SPO13*), middle (*SPS4*), and late (*SPS100*) meiotic mRNAs in either *UME6* (RSY1079)-expressing or *UME6^KallR^* (RSY1149)-expressing stains after transfer to SPM as indicated. Western blot analysis was used to monitor Ume6p and Ume6p^KallR^ levels (bottom) at the same time points. (B) Wild-type (RSY1079, open circles) and Ume6p^KallR^ (RSY1149)-expressing (open squares) and Ume6p^KallQ^ (RSY1226)-expressing (closed diamonds) strains were induced to enter meiosis and time points taken as indicated. The percentages of cells containing multiple nuclei indicating the execution of at least one meiotic nuclear division were determined by DAPI staining.

Genes composing the middle and late expression classes are required for execution of the meiotic nuclear divisions and spore wall assembly, respectively. Therefore we next examined the affect of the altered transcription of middle and late genes on these processes. DAPI staining of meiotic nuclei was used to quantitate the fraction of the population undergoing meiosis I (binucleates) or meiosis I and II (tetranucleates). These studies revealed that the appearance of binucleated or tetranucleated cells was delayed in the Ume6p^KallR^-expressing strain compared with wild type ([Figure 6B](#F6){ref-type="fig"}). By 24 h, 27% of the Ume6p^KallR^-expressing strain had undergone both divisions compared with 92% for the wild type. Although the initial appearance of multinucleated cells in Ume6p^KallQ^-expressing strains occurred with similar kinetics as wild type, the final percentage of the population undergoing any meiotic divisions was reduced. These results indicate that the correct timing of Ume6p destruction is important for normal execution of the meiotic nuclear divisions (see *Discussion*). Finally, we analyzed the viability of spores derived from these diploids. No differences were observed in spore appearance, viability, or sensitivity to enzymatic digestion (unpublished data). These results indicate that although the overall meiotic division completion efficiency was reduced, the spores that were produced appeared normal.

DISCUSSION
==========

Ume6p destruction is required for induction of EMGs and execution of meiosis and spore formation. This proteolysis is accomplished by a two-step process that is controlled by both endogenous and exogenous signals ([@B28]; for review see [@B13]). The first step, which results in ∼50% reduction in Ume6p levels and partial derepression of EMG, occurs when vegetative cultures are switched from dextrose to a nonfermentable carbon-based medium. The second step, resulting in the complete elimination of Ume6p and full EMG induction, requires the withdrawal of a nitrogen source and the direct association of the meiotic protein Ime1p. In the present study, we find that the initial step in this degradation program is regulated by Ume6p acetylation and deacetylation by the Gcn5p-dependent acetyltransferase complex SAGA and the HDAC Rpd3p, respectively. Specifically, acetylation at a cluster of three lysines is required for step 1 Ume6p destruction and partial EMG derepression. In addition, substitution mutations that either prevent or mimic acetylation retard or accelerate step 2 meiotic Ume6p destruction, respectively. These results suggest that these two steps are connected. Of interest, either hastening or delaying Ume6p destruction reduced the efficiency of meiosis I and II execution. These findings indicate that the fine-tuning of Ume6p destruction by acetylation is important for normal meiotic progression.

Acetyltransferases induce transcription by enhancing the activity of transcriptional activators and opening chromatin domains. The present study defines a third avenue by which gene activation is accomplished by acetylation, through the targeted destruction of the Ume6p repressor. Lysine acetylation is usually associated with protecting proteins from proteolysis by serving as a block to ubiquitylation ([@B35]). A potential exception to this rule was the report that acetylation of the hypoxic transcription factor HIF1-α by the N-terminal acetyltransferase ARD1 stimulated its proteolysis ([@B22]). This result was surprising, given the mostly cytoplasmic localization of ARD1 and its function as an N-terminal α-acetyltransferase rather than as targeting the ε-amino group of lysine like ubiquitin ligases or Gcn5p (reviewed in [@B26]). Moreover, two subsequent reports found no connection between ARD1 function and HIF1-α stability ([@B1]; [@B4]), bringing the initial result into question. The combination of in vitro and in vivo studies presented in the present study provides solid evidence for the regulated acetylation of a transcriptional repressor and the role of this modification in promoting APC/C-dependent destruction.

Gcn5p-dependent acetyltransferase activity stimulates partial Ume6p degradation when the cells are switched from dextrose to acetate media. In many differentiation pathways, transcriptional programs provide a series of gates that allows flexibility in cell fate decisions. For example, in hematopoietic stem cell differentiation, changes in the levels of the transcription factor PU.1 help to refine the gene expression profile to push the cell toward macrophage differentiation ([@B27]). A similar scenario may be occurring when yeast cells switch from a fermentable to a nonfermentable carbon source. Yeast will ferment various sugars, producing ethanol as a byproduct. When the sugar is exhausted, yeast will use the ethanol as a carbon source through mitochondrial-dependent respiration. Partial reduction in Ume6p levels induced by acetylation results in low-level derepression of EMG and rapid execution of meiosis upon further stimulation. A similar fate is observed for the yeast C-type cyclin. Along with its kinase Cdk8p, cyclin C also represses EMG transcription ([@B37]) through its interaction with the mediator complex ([@B12]). Similar to Ume6p, cyclin C levels are reduced to approximately half when cultures are shifted from dextrose to ethanol- or acetate-based medium ([@B11]). Final destruction of cyclin C, which is also required for full EMG induction, occurs upon meiotic entry ([@B10]). These findings argue that a general down-regulation of EMG transcriptional repressors in acetate medium represents a "potentiated state" of the cell that allows rapid transition from mitosis to meiosis when nitrogen sources are exhausted.

The transition from mitotic to meiotic cell division requires Ime1p, a protein necessary for the complete Ume6p destruction ([@B28]). Although still a possibility, it seems unlikely that acetylation recruits Ime1p, as the Ume6p-Ime1p association domain ([@B34]) and acetylated lysines are on opposite ends of the protein ([Figure 1D](#F1){ref-type="fig"}). In addition, in vitro studies revealed no difference between the association of Ime1p to Ume6p or to Ume6p^KallQ^ (unpublished results). A previous study suggested that one potential function of Ime1p is to disrupt the association of Ume6p to the Sin3p-Ume1p-Rpd3p HDAC complex ([@B30]). The removal of Rpd3p from EMG promoters could serve two purposes. First, it would allow further acetylation of Ume6p, which would stimulate its destruction. Second, the surrounding histones would also become more likely acetylated due to the loss of Rpd3p from the promoter. Under step 1 destruction conditions (acetate-grown vegetative cells), Ime1p is not expressed, thus retaining Rpd3p at the EMG promoter and setting up a competition between this HDAC and Gcn5p activity to determine Ume6p acetylation status. This model is supported by our analysis of *cis* and *trans* mutations that throw the acetylation balance in one direction or the other. For example, mimicking acetylation (KallQ) promotes Ume6p step 1 destruction in the absence of Gcn5p. Similarly, deleting *RPD3* enhances Ume6p destruction in acetate cultures. This constant interplay between these two activities is illustrated by our finding that although Ume6p is acetylated in acetate cultures, it is only partially destroyed compared with the KallQ mutant, which the cell may recognize as always acetylated. Taken together, these findings suggest that the interplay between Rpd3p and Gcn5p activities controls the acetylation status and stability of Ume6p, which in turn regulates meiotic entry and progression.

MATERIALS AND METHODS
=====================

Plasmids and strains
--------------------

All strains used in this study are listed in Supplemental Table S1 and derived from a cross between a rapid sporulating (SK1) background and a strain (W303) that does not precociously enter meiosis. All *UME6* derivatives were constructed by oligonucleotide-directed mutagenesis and then introduced into its normal chromosomal location using the pop-in, pop-out method ([@B33]) and were verified by sequence analysis of the chromosomal allele. The various derivatives were introduced into this vector by replacing the *Sph*I-*Hin*dIII fragment of the wild-type and mutant constructs. Conditional alleles were generated by placing the *UME6* or *UME6^K745R^* coding region under the control of the *GAL1* promoter in pGALSET985 ([@B14]), forming pMM225 and pMM482, respectively. *GAL1~pro~*-*UME6* induction was accomplished in acetate cultures by addition of galactose (0.5%). GST-Ume6p^721-831^ (pMM421) was constructed by insertion of the PCR-amplified DNA into pGEX1λT. Site-directed mutagenesis on these plasmids was accomplished as described ([@B25]) on M13-derived, single-stranded DNA.

Acetylation/deacetylation assays
--------------------------------

For in vitro assays, SAGA and ADA complexes were obtained using affinity purification (His~6~-*ADA2*) and further separated by ion exchange chromatography as described previously ([@B18]). Recombinant His~6~-Gcn5p (rGcn5) was purified from *Escherichia coli* as described ([@B7]). Approximately 10 μg of GST-Ume6p substrate purified from *E. coli* or unacetylated histones was used in each reaction. Acetylation activity of SAGA and ADA HAT complexes with Ume6p and histones was quantitated by spotting the reactions on P81 paper, washing the filters extensively to remove unbound ^3^H-acetyl-CoA, and counting the remaining radioactivity by liquid scintillation spectroscopy. In vivo labeling of acetylated proteins was achieved by incubating mid-log cultures harboring the *GAL1~pro~-T7-UME6* expression construct (pMM225) or the vector control with ^14^C-acetyl-CoA (500 μCi) for 2 h. Deacetylation assays were conducted using the in vitro Ume6p acetylation reaction just described, followed by heat inactivation of SAGA and addition of 0.4 μg of HDAC1 (Cell Sciences, Canton, MA). Reactions were inactivated by boiling after 0, 2, and 4 h and separated by PAGE, and the resulting gel was incubated in Amplify (GE Healthcare, Piscataway, NJ) before fluorography.

Western blot analysis
---------------------

Extracts were prepared from vegetative and meiotic cultures as described previously ([@B10]) in the presence of 10 mM Na butyrate and 0.1% trichostatin A to inhibit HDAC activity. Either 1 mg or 100 μg of soluble protein was used for immunoprecipitation and straight Western blot experiments, respectively. Polyclonal antibodies were generated in rabbits against peptides containing acetylated K736, K737, K745, and the double-modified K736,737 (Open Biosystems, Thermo Biosystems, Huntsville, AL). Only α-K736-Ac and α-K745-Ac antibodies were produced with sufficient specificity to be useful. The antibodies were affinity purified and concentrated after preclearing with the unmodified peptide. T7 antibodies were obtained from Novagen (EMD4Biosciences, Gibbstown, NJ). Chemiluminescence signals were quantitated by charge-coupled device camera imaging (Kodak, Rochester, NY).

Gene expression analyses
------------------------

Northern blot analysis was conducted as previously described ([@B9]). Quantitative PCR was conducted using SYBR green protocols (Applied Biosystems, Foster City, CA) with the oligonucleotides described in Supplemental Table 2. Using delta Ct values, we first standardized all mRNA levels to internal *ENO1* transcript levels. We then set *SPO13* or *UME6* mRNA levels in wild-type cultures grown in dextrose medium at 100%. The SEM from three biological repeats is indicated.

Cell culture conditions
-----------------------

Cell growth and meiotic time-course experiments were conducted essentially as described previously ([@B28]). Meiotic time-course experiments were conducted by transferring washed, mid-log-phase cells grown in potassium acetate medium to SPM containing 2% potassium acetate. For protein stability assays, *UME6* or *UME6^K745R^* was placed under the control of the galactose promoter and introduced into a wild-type strain (RSY10). Cultures were grown to mid-log phase in minimal acetate medium to allow Ume6p acetylation by Gcn5p. Galactose (0.5%) and nocodazole (15 μg/ml) were added for 3 h to induce *UME6* and *UME6^K745R^* expression and arrest the cultures in G2, respectively. Culture arrest was confirmed by DAPI analysis, with \>80% of the cells containing a large bud with a single nucleus. After arrest, the cells were washed and placed into glucose medium to repress the *GAL1* promoter, and cycloheximide was added (50 μg/ml) to stop protein synthesis. Samples were taken as indicated in the text, and Ume6p and Ume6p^K745R^ levels were determined by Western blot analysis. The corresponding signals were quantified (Kodak Imager), and half-life calculations were made by linear regression after normalization to the Tub1p internal standard. For all lines used in the analysis r = −0.99. The graph represents the average of two independent experiments.

Supplementary Material
======================

###### Supplemental Materials

This article was published online ahead of print in MBoC in Press ([http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E11-06-0536](http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E12-02-0140)) on March 21, 2012.

We thank K. Cooper and M. Primig for helpful discussions during the course of this work. We also thank S. Seeholzer and the Biochemistry and Biotechnology Facility at the Fox Chase Cancer Center for mass spectroscopy analysis. This work was supported by National Institute of Health Grants GM082013 (M.L.) and GM086788 (R.S.).

APC/C

:   anaphase-promoting complex/cyclosome

EMG

:   early meiotic genes

HAT

:   histone acetyltransferase

HDAC

:   histone deacetylase

[^1]: \*These authors contributed equally to this study.

[^2]: ^†^Present address: Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA 19104.

[^3]: The authors have no financial conflicts with this study.
